Joel Greenblatt Intercept Pharmaceuticals, Inc. Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$48.35 - $118.68 $220,814 - $542,011
-4,567 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$57.36 - $124.1 $261,963 - $566,764
4,567 New
4,567 $566,000
Q2 2019

Aug 14, 2019
SELL
$77.77 - $120.68 $214,645 - $333,076
-2,760 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$91.83 - $120.68 $253,450 - $333,076
2,760 New
2,760 $309,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email